Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166388 | SCV000217180 | uncertain significance | Hereditary cancer-predisposing syndrome | 2014-10-15 | criteria provided, single submitter | clinical testing | The c.7387_7389delCTT variant (also known as p.L2463DEL) located in coding exon 50 of the NF1 gene. This variant results from an in-frame CTT deletion between nucleotide positions 7387 and 7389. This results in the loss of a single leucine residue at codon 2463. In one study, a review of patient reports in the literature, research mutation databases, and unpublished cases described this variant in one individual with a NF1-Noonan syndrome phenotype (<span data-redactor="verified" style="background-color: initial;">Ben-Shachar S et al. Eur. J. Hum. Genet. 2013 May; 21(5):535-9).<span data-redactor="verified" style="background-color: initial;">This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position.<span style="background-color: initial;">To date, this alteration has been detected with an allele frequency of approximately 0.02% (greater than 11000 alleles tested) in our clinical cohort. <span data-redactor="verified" style="background-color: initial;">This amino acid position is highly conserved in available higher vertebrate species.<span data-redactor="verified" style="background-color: initial;">Since supporting evidence is limited at this time, the clinical significance of<span data-redactor="verified" style="background-color: initial;">c.7387_7389delCTT<span data-redactor="verified" style="background-color: initial;">remains unclear. |
Labcorp Genetics |
RCV000632330 | SCV000753507 | uncertain significance | Neurofibromatosis, type 1 | 2023-11-08 | criteria provided, single submitter | clinical testing | This variant, c.7324_7326del, results in the deletion of 1 amino acid(s) of the NF1 protein (p.Leu2442del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs760990926, gnomAD 0.05%). This variant has been observed in individual(s) with neurofibromatosis-Noonan syndrome (PMID: 23047742). This variant is also known as c.7324delCTT. ClinVar contains an entry for this variant (Variation ID: 186743). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001552078 | SCV001772701 | likely benign | not provided | 2019-07-22 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acids in a non-repeat region; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 23047742) |
Ambry Genetics | RCV002381531 | SCV002669759 | benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2022-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001552078 | SCV003815863 | uncertain significance | not provided | 2022-03-30 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV004703438 | SCV004222183 | likely benign | not specified | 2023-01-11 | criteria provided, single submitter | clinical testing | The frequency of this variant in the general population (http://gnomad.broadinstitute.org) is higher than would generally be expected for pathogenic variants in this gene. |